Literature DB >> 10066665

Variants of a Cryptococcus neoformans strain elicit different inflammatory responses in mice.

L C Chen1, A Casadevall.   

Abstract

The virulence of Cryptococcus neoformans isolates with high and low extracellular proteolytic activity was investigated in mice. No consistent relationship between proteolytic activity and virulence was observed, but isolates derived from one strain were shown to elicit different inflammatory responses.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10066665      PMCID： PMC95698          DOI： 10.1128/CDLI.6.2.266-268.1999

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


  11 in total

1.  Characterization of the biological activity of Cryptococcus infections in surgical pathology. The Budding Index and Carminophilic Index.

Authors:  D A Schwartz
Journal:  Ann Clin Lab Sci       Date:  1988 Sep-Oct       Impact factor: 1.256

2.  Extracellular proteins of Cryptococcus neoformans and host antibody response.

Authors:  L C Chen; L A Pirofski; A Casadevall
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

3.  Extracellular proteinase activity of Cryptococcus neoformans.

Authors:  L C Chen; E S Blank; A Casadevall
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

4.  Cryptococcosis in beige mice: the effect of congenital defects in innate immunity on susceptibility.

Authors:  C A Salkowski; E Balish
Journal:  Can J Microbiol       Date:  1991-02       Impact factor: 2.419

5.  Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection.

Authors:  M Feldmesser; A Casadevall
Journal:  J Immunol       Date:  1997-01-15       Impact factor: 5.422

6.  Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes.

Authors:  S P Franzot; J Mukherjee; R Cherniak; L C Chen; J S Hamdan; A Casadevall
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

7.  Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains.

Authors:  J Mukherjee; M D Scharff; A Casadevall
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

8.  Proteolytic activity of a clinical isolate of Cryptococcus neoformans.

Authors:  C H Brueske
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

Review 9.  What makes Cryptococcus neoformans a pathogen?

Authors:  K L Buchanan; J W Murphy
Journal:  Emerg Infect Dis       Date:  1998 Jan-Mar       Impact factor: 6.883

10.  Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell.

Authors:  J Mukherjee; G Nussbaum; M D Scharff; A Casadevall
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307
View more
  7 in total

Review 1.  Phenotypic switching and its implications for the pathogenesis of Cryptococcus neoformans.

Authors:  Neena Jain; Abraham Guerrero; Bettina C Fries
Journal:  FEMS Yeast Res       Date:  2006-06       Impact factor: 2.796

2.  Effects of antifungal interventions on the outcome of experimental infections with phenotypic switch variants of Cryptococcus neoformans.

Authors:  Bettina C Fries; Emily Cook; Xiabo Wang; Arturo Casadevall
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

3.  Loss of allergen 1 confers a hypervirulent phenotype that resembles mucoid switch variants of Cryptococcus neoformans.

Authors:  Neena Jain; Li Li; Ye-Ping Hsueh; Abraham Guerrero; Joseph Heitman; David L Goldman; Bettina C Fries
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

4.  Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection.

Authors:  B C Fries; C P Taborda; E Serfass; A Casadevall
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

5.  Phenotypic switching of Cryptococcus neoformans can produce variants that elicit increased intracranial pressure in a rat model of cryptococcal meningoencephalitis.

Authors:  B C Fries; S C Lee; R Kennan; W Zhao; A Casadevall; D L Goldman
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

6.  Do kinetics of the humoral response to Cryptococcus neoformans proteins during murine cryptococcosis reflect outcome?

Authors:  S Neuville; O Lortholary; F Dromer
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

7.  Use of Clinical Isolates to Establish Criteria for a Mouse Model of Latent Cryptococcus neoformans Infection.

Authors:  Minna Ding; Kyle D Smith; Darin L Wiesner; Judith N Nielsen; Katrina M Jackson; Kirsten Nielsen
Journal:  Front Cell Infect Microbiol       Date:  2022-02-02       Impact factor: 6.073
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.